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Summary. We reviewed the literature concerning the 
history of determination of the ploidy of human mega- 
karyocytes and its relationship with diseases. The ploidy 
of rabbit megakaryocytes was analyzed by microspectro- 
photometry in 1964, and the analysis of the ploidy in 
human megakaryocytes was first performed in 1968. 
Presently, microphotometry and flow cytometry are the 
primary methods for the evaluation of the ploidy, but 
they have their merits and demerits. In the ploidy of 
human megakaryocytes, a peak has often been reported 
at 16N in healthy individuals, and the next peaks have 
been observed at 32N and 8N. The results of ploidy 
analyses have been reported by many investigators to be 
comparable between patients with idiopathic thrombo- 
cytopenic purpura and normal subjects, but various shifts 
of the peaks have also been documented. The ploidy is 
often reported to shift to a larger ploidy class in poly- 
cythemia vera and essential thrombocythemia, but it has 
invariably been reported to shift to a smaller class in 
chronic myelogenous leukemia. In reactive thrombo- 
cytosis, the ploidy pattern was reported to be the same as 
that in normal individuals by some investigators but to 
shift to a larger ploidy by others. These differences are 
considered to be due to heterogeneity of the subjects. In 
myelodysplastic syndrome, the ploidy shifts mostly to a 
smaller class, but it may show various patterns. We also 
reviewed the ploidy in other rare hematological 
disorders, the relationships of the ploidy with diabetes 
mellitus and atherosclerotic disorders, and its changes in 
the ontogeny. Details of the mechanism of polyploidi- 
zation and its biological significance remain unknown, 
and further advances in the studies of these topics are 
anticipated. 
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Introduction 
Megakaryocytes, named by Howell in 1890, are 
unique and mysterious cells that are physiologically 
polyploidy. However, there have not been many studies 
of qualitative differences of individual megakaryocytes, 
because of their low frequency in bone marrow cells and 
the wide variation in their shape and size. The ploidy of 
megakaryocytes was first analyzed in 1943 by Japa 
using the nuclear lobe counting method, but direct 
measurement of DNA content of megakaryocytes is 
considered to have been first made by Garcia in rabbits 
by microspectrophotometry using the two-wavelength 
method in 1964 (a,b). The measurement of megakaryo- 
cyte ploidy was first applied to humans by de Leval in 
1968. There have since been many studies on the ploidy 
of megakaryocytes. In this article, our data and the 
reports to date concerning human megakaryocyte ploidy 
are reviewed. 
Methods for ploidy analysis 
Although there are several methods for ploidy 
analysis,  they may be generally categorized as  
microphotometry and flow cytometry (FCM). 
FCM, by which a large number of cells can be 
counted instantaneously, is naturally a very useful 
technique. However, the counting of rnegakaryocytes, 
which account for only a small percent of bone marrow 
cells, have large sizes and vary in shape, is difficult, and 
approaches such as the enrichment of megakaryocytes 
andlor the exclusive marking of megakaryocytes are 
necessary. Nakeff et al.  (1979) were the first  
investigators to use FCM for the measurement of DNA 
in mouse and rat megakaryocytes. In that study, they 
observed cells after enriching megakaryocytes by 
centrifugal elutriation and staining them with Hoechst 
33342. In 1984, Jackson et al. and Worthington et al. 
labeled rat megakaryocytes with fluorescein isothio- 
cyanate (FITC) using an antiplatelet antibody and 
measured the DNA content by propidium iodide (PI) 
staining. Probably because human megakaryocytes are 
larger than those of rats and since it is difficult to acquire 






